BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19058617)

  • 1. Expanding research capacity and accelerating AIDS vaccine development in Asia.
    Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
    Kent SJ; Cooper DA; Chhi Vun M; Shao Y; Zhang L; Ganguly N; Bela B; Tamashiro H; Ditangco R; Rerks-Ngarm S; Pitisuttithum P; Van Kinh N; Bernstein A; Osmanov S;
    PLoS Med; 2010 Sep; 7(9):e1000331. PubMed ID: 20877474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
    AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
    Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
    Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
    [No Abstract]   [Full Text] [Related]  

  • 6. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. India to develop its own AIDS vaccine.
    Jayaraman KS
    Nat Med; 1998 Jan; 4(1):7. PubMed ID: 9427585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grappling with global concerns in the search for an HIV vaccine.
    Grady C
    J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.
    Voronin Y; Manrique A; Bernstein A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):414-20. PubMed ID: 20978383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.
    Ferrantelli F; Buttò S; Cafaro A; Wahren B; Ensoli B
    Springer Semin Immunopathol; 2006 Nov; 28(3):289-301. PubMed ID: 16983452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    Global HIV/AIDS Vaccine Enterprise
    PLoS Med; 2005 Feb; 2(2):e25. PubMed ID: 15740411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
    Adis International Ltd
    Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccines for HIV: challenges and opportunities.
    Hokey DA; Weiner DB
    Springer Semin Immunopathol; 2006 Nov; 28(3):267-79. PubMed ID: 17031649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccine research: the challenge and the way forward.
    Wang HB; Mo QH; Yang Z
    J Immunol Res; 2015; 2015():503978. PubMed ID: 25861656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive HIV-1 vaccines: where are we going?
    Kent SJ
    Int J STD AIDS; 1998 Dec; 9(12):715-9. PubMed ID: 9874116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.